Thu, July 3, 2025
Wed, July 2, 2025
Tue, July 1, 2025
Mon, June 30, 2025
Sun, June 29, 2025
Sat, June 28, 2025
Fri, June 27, 2025
Thu, June 26, 2025
Wed, June 25, 2025
Tue, June 24, 2025
[ Tue, Jun 24th ]: 13abc
Moment of Science: Copper
Mon, June 23, 2025
Sun, June 22, 2025
Sat, June 21, 2025
Fri, June 20, 2025
Thu, June 19, 2025
Wed, June 18, 2025
Tue, June 17, 2025
[ Tue, Jun 17th ]: MLB
Yankees Mag: Life Sciences
Mon, June 16, 2025
Sun, June 15, 2025
Sat, June 14, 2025
Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025

Are U.S. Pharma Companies Ready To Bring Life Science Manufacturing Home?


  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. dy-to-bring-life-science-manufacturing-home.html
  Print publication without navigation Published in Science and Technology on by Forbes
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source


  For the pharma industry, the question becomes: How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

The article from Forbes Business Development Council, published on June 11, 2025, discusses the readiness of U.S. pharmaceutical companies to bring life science manufacturing back to the United States. It highlights the increasing interest in reshoring due to supply chain vulnerabilities exposed by global events like the COVID-19 pandemic. The piece examines the challenges and opportunities associated with this shift, including the need for significant investment in infrastructure, workforce development, and regulatory adjustments. It also notes the potential benefits such as enhanced control over production, reduced dependency on foreign suppliers, and the stimulation of local economies. The article concludes by emphasizing the importance of strategic planning and collaboration between government, industry, and academia to successfully transition life science manufacturing back to the U.S.

Read the Full Forbes Article at:
[ https://www.forbes.com/councils/forbesbusinessdevelopmentcouncil/2025/06/11/are-us-pharma-companies-ready-to-bring-life-science-manufacturing-home/ ]

Publication Contributing Sources

Similar Science and Technology Publications